Skip to content
← Holders

Acuta Capital Partners, LLC

What Acuta Capital Partners, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1582844 · Filed Nov 16, 2026

Positions
35
Reported value
$131.6M
Opened
12
Closed
0
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$96.8M
    28 positions
  2. Dec 31, 2025$147.3M
    30 positions
  3. Mar 31, 2026$141.8M
    27 positions
  4. Jun 30, 2026$143.5M
    23 positions
  5. Sep 30, 2026$131.6M
    35 positions
SecuritySharesChangeValueOf portfolio
PRAXPraxis Precision Medicines, Inc.
84.2K+1.7%$24.5M18.6%
WHWKWhitehawk Therapeutics, Inc.
4.7M±0%$17.6M13.4%
TNGXTango Therapeutics, Inc.
409.5K+4.8%$10.2M7.8%
FDMT4D Molecular Therapeutics, Inc.
535.1K+5.4%$7.7M5.8%
ARGXArgenx SE
5.6K+18.1%$5.3M4%
AVBPArriVent BioPharma, Inc.
170.9K−21.9%$5.2M3.9%
SRZNSurrozen, Inc.
152.5K−12.0%$4.9M3.7%
VOGXVogenx, Inc.
213.2KNew$4.9M3.7%
DRUGBright Minds Biosciences Inc.
93.2K+0.4%$4.6M3.5%
OCULOcular Therapeutix, Inc
574.5K+7.9%$4.4M3.3%
SLNSilence Therapeutics plc
393.6KNew$4.3M3.3%
TSHATaysha Gene Therapies, Inc.
691.8K+23.1%$3.4M2.6%
AVLNAvalyn Pharma Inc.
114.7K−0.2%$3.3M2.5%
AVTXAvalo Therapeutics, Inc.
186.3K±0%$2.9M2.2%
MLTXMoonLake Immunotherapeutics
216.6K+0.4%$2.5M1.9%
IRDOpus Genetics, Inc.
514.1KNew$2.5M1.9%
NERVMinerva Neurosciences, Inc.
729.5K+2.8%$2.4M1.9%
LBRXLB Pharmaceuticals Inc
52.7K+82.3%$2M1.5%
ACADAcadia Pharmaceuticals IncCall option
1KNew$2M1.5%
ARTVArtiva Biotherapeutics, Inc.
260.4K±0%$1.9M1.4%
AMLXAmylyx Pharmaceuticals, Inc.
63K−62.6%$1.8M1.4%
RVMDRevolution Medicines, Inc.
8.2KNew$1.7M1.3%
IRLAIRulya Therapeutics Inc.
52.9KNew$1.6M1.2%
ROIVRoivant Sciences Ltd.
41.5KNew$1.5M1.2%
DSGNDesign Therapeutics, Inc.
115.4K−59.2%$1.5M1.1%
UTHRUnited Therapeutics Corp
2.2K+0.7%$1.2M0.9%
CTNMContineum Therapeutics, Inc.
89.8K+42.4%$1.2M0.9%
ORICOric Pharmaceuticals, Inc.
87.9KNew$1.2M0.9%
ERASErasca, Inc.
67.5K−74.5%$990.2K0.8%
ANTXAN2 Therapeutics, Inc.
142.1KNew$755.7K0.6%
ADILAzora Therapeutics, Inc. (DE)
130KNew$521.2K0.4%
STROSutro Biopharma, Inc.
25.3K−90.6%$407.4K0.3%
EQEquillium, Inc.
183KNew$297.4K0.2%
CMPXCompass Therapeutics, Inc.
251K−57.8%$261K0.2%
STOKStoke Therapeutics, Inc.
5.8KNew$150K0.1%